作者：
Catherine,Ashton [1]
;
Elisabetta,Indelicato [2]
;
David,Pellerin [3]
;
Guillemette,Clément [1]
;
Matt C,Danzi [4]
;
Marie-Josée,Dicaire [5]
;
Céline,Bonnet [6]
;
Henry,Houlden [7]
;
Stephan,Züchner [8]
;
Matthis,Synofzik [1]
;
Phillipa J,Lamont [5]
;
Mathilde,Renaud [9]
;
Sylvia,Boesch [4]
;
Bernard,Brais [8]
作者单位：
Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC H3A 2B4, Canada.
[1]
Department of Neurology, Royal Perth Hospital, Perth, WA 6007, Australia.
[2]
Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University of Innsbruck, Innsbruck 6020, Austria.
[3]
Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London, London WC1N 3BG, UK.
[4]
INSERM-U1256 NGERE, Université de Lorraine, 54500 Vandoeuvre-les-Nancy, France.
[5]
Service de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, 54000 Nancy, France.
[6]
Service de Génétique Clinique, Centre Hospitalier Régional Universitaire de Nancy, 54000 Nancy, France.
[7]
Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33176, USA.
[8]
Laboratoire de Génétique, Centre Hospitalier Régional Universitaire de Nancy, 54000 Nancy, France.
[9]
Division of Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, 72076 Tübingen, Germany.
[10]
German Center for Neurodegenerative Diseases (DZNE), 72076 Tübingen, Germany.
[11]
Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada.
[12]
Clinique des maladies neuromusculaires. Centre de Réadaptation Lucie-Bruneau, Montreal, QC H2H 2N8, Canada.
[13]
DOI
10.1093/braincomms/fcad239
PMID
37705681
发布时间
2024-03-20
换一批
换一批
